Advanced search
Publication Cover
Climacteric Volume 18, 2015 - Issue 3
Submit an article Journal homepage
250
Views
6
CrossRef citations to date
0
Altmetric
COMMENTARY

A Commentary on a recent update of the ovarian cancer risk attributable to menopausal hormone therapy

A. GompelUnité de Gynécologie Endocrinienne, Université Paris Descartes, APHP, Cochin Port Royal, Paris, FranceCorrespondence[email protected]
&
H. Burger *MIMR/PHI Institute of Medical Research, Clayton, Victoria, Australia
Pages 376-378 | Received 22 Feb 2015, Accepted 24 Feb 2015, Published online: 27 Mar 2015

References

  • Collaborative Group on Epidemiological Studies of Ovarian Cancer. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet 2015 Feb 12. doi: 10.1016/S0140-6736(14)61687-1. Epub ahead of print
  • Tsilidis KK, Allen NE, Key TJ, et al. Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition. Cancer Causes Control 2011;22:1075–84
  • Mørch LS, Løkkegaard E, Andreasen AH, Krüger-Kjaer S, Lidegaard O. Hormone therapy and ovarian cancer. JAMA 2009;302:298–305
  • Beral V, Reeves G, Green J, Bull D, for the Million Women Study Collaborators. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 2007;369: 1703–10
  • Pearce CL, Chung K, Pike MC, Wu AH. Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin. Cancer 2009;115:531–9
  • Gompel A, Plu-Bureau G. Ovarian cancer and hormone replacement therapy. Lancet 2007;370:932
  • Beral V, Bull D, Green J, Reeves G, on behalf of the Million Women Study collaborators Ovarian cancer and hormone replacement therapy. Lancet 2007;370:932–3
  • World Health Organization, mortality database. http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html (accessed on 17/11/2014)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.